| Clinical outcomes in patients after surgical and transcatheter aortic valve replacement T Tokarek, R Sobczyński, A Dziewierz, Z Siudak, W Zasada, D Sorysz, ... Polskie Archiwum Medycyny Wewnętrznej= Polish Archives of Internal Medicine …, 2015 | 37 | 2015 |
| Fibrosis of extracellular matrix is related to the duration of the disease but is unrelated to the dynamics of collagen metabolism in dilated cardiomyopathy P Rubiś, S Wiśniowska-Śmialek, E Wypasek, B Biernacka-Fijalkowska, ... Inflammation Research 65, 941-949, 2016 | 29 | 2016 |
| Mortality risk in dilated cardiomyopathy: the accuracy of heart failure prognostic models and dilated cardiomyopathy‐tailored prognostic model E Dziewięcka, M Gliniak, M Winiarczyk, A Karapetyan, ... ESC heart failure 7 (5), 2455-2467, 2020 | 26 | 2020 |
| The relationship between myocardial fibrosis and myocardial micro RNA s in dilated cardiomyopathy: A link between mir‐133a and cardiovascular events P Rubiś, J Totoń‐Żurańska, S Wiśniowska‐Śmiałek, E Dziewięcka, ... Journal of Cellular and Molecular Medicine 22 (4), 2514-2517, 2018 | 26 | 2018 |
| Prognostic value of fibrosis-related markers in dilated cardiomyopathy: a link between osteopontin and cardiovascular events P Rubiś, S Wiśniowska-Śmiałek, E Dziewięcka, L Rudnicka-Sosin, ... Advances in medical sciences 63 (1), 160-166, 2018 | 20 | 2018 |
| Relations between circulating and myocardial fibrosis-linked microRNAs with left ventricular reverse remodeling in dilated cardiomyopathy E Dziewięcka, J Totoń-Żurańska, P Wołkow, M Kołton-Wróż, E Pitera, ... Advances in Clinical and Experimental Medicine 29 (3), 2020 | 15 | 2020 |
| Extracellular volume is an independent predictor of arrhythmic burden in dilated cardiomyopathy PP Rubiś, EM Dziewięcka, P Banyś, M Urbańczyk-Zawadzka, M Krupiński, ... Scientific reports 11 (1), 24000, 2021 | 12 | 2021 |
| Left ventricular reverse remodeling is not related to biopsy-detected extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy, regardless of the … P Rubiś, S Wiśniowska-Śmiałek, B Biernacka-Fijałkowska, ... Heart and vessels 32, 714-725, 2017 | 10 | 2017 |
| Relationships between circulating galectin-3, extracellular matrix fibrosis and outcomes in dilated cardiomyopathy P Rubiś, K Holcman, E Dziewięcka, S Wiśniowska-Śmiałek, ... Advances in Clinical and Experimental Medicine 30 (3), 2021 | 9 | 2021 |
| Relationships between pulmonary hypertension risk, clinical profiles, and outcomes in dilated cardiomyopathy E Dziewięcka, S Wiśniowska-Śmiałek, A Karabinowska, K Holcman, ... Journal of clinical medicine 9 (6), 1660, 2020 | 9 | 2020 |
| The burden of atrial fibrillation and its prognostic value in patients with dilated cardiomyopathy E Dziewięcka, M Gliniak, M Winiarczyk, A Karapetyan, ... Polish Heart Journal (Kardiologia Polska) 78 (1), 37-44, 2020 | 8 | 2020 |
| Nowe metody diagnostyki amyloidozy serca: seria przypadków amyloidozy transtyretynowej P Rubiś, E Dziewięcka, K Holcman, W Szot, S Wiśniowska-Śmiałek, ... Hematologia 9 (3), 2018 | 8 | 2018 |
| Kinetics of selected serum markers of fibrosis in patients with dilated cardiomyopathy and different grades of diastolic dysfunction of the left ventricle S Wiśniowska-Śmiałek, E Dziewięcka, K Holcman, E Wypasek, ... Cardiology Journal 27 (6), 726-734, 2020 | 6 | 2020 |
| Lack of relationship between fibrosis-related biomarkers and cardiac magnetic resonance-assessed replacement and interstitial fibrosis in dilated cardiomyopathy P Rubiś, E Dziewięcka, M Szymańska, R Banyś, M Urbańczyk-Zawadzka, ... Cells 10 (6), 1295, 2021 | 5 | 2021 |
| Mortality risk assessment in dilated cardiomyopathy: the Krakow DCM Risk Score E Dziewięcka, P Rubiś Polish Heart Journal (Kardiologia Polska) 79 (2), 215-216, 2021 | 5 | 2021 |
| Comparison of clinical course and outcomes between dilated and hypokinetic non-dilated cardiomyopathy E Dziewięcka, M Winiarczyk, S Wiśniowska-Śmiałek, ... Cardiology 148 (5), 395-401, 2023 | 4 | 2023 |
| Fibrin clot properties and thrombin generation in hypertrophic cardiomyopathy P Rubiś, J Natorska, M Ząbczyk, E Dziewięcka, A Karabinowska, ... Thrombosis and Haemostasis 120 (01), 181-183, 2020 | 4 | 2020 |
| Link between fibrosis-specific biomarkers and interstitial fibrosis in hypertrophic cardiomyopathy A Karabinowska-Małocha, E Dziewięcka, M Szymańska, P Banyś, ... Kardiologia Polska (Polish Heart Journal) 81 (7-8), 692-699, 2023 | 3 | 2023 |
| The Relationship between Cardiac Magnetic Resonance-Assessed Replacement and Interstitial Fibrosis and Ventricular Arrhythmias in Hypertrophic Cardiomyopathy A Karabinowska-Małocha, E Dziewięcka, P Banyś, ... Journal of Personalized Medicine 12 (2), 294, 2022 | 3 | 2022 |
| Clinical Utility and Validation of the Krakow DCM Risk Score—A Prognostic Model Dedicated to Dilated Cardiomyopathy E Dziewięcka, M Winiarczyk, S Wiśniowska-Śmiałek, ... Journal of Personalized Medicine 12 (2), 236, 2022 | 2 | 2022 |
